John Chionis

John received his B.S. in Biology from UC Davis in 2002 and has since worked at various biotechnology companies, most recently at Pfizer where he spent the last 13 years working on target identification and translational programs developing small molecule inhibitors for oncology. While at Pfizer he was a Research Project Lead identifying synthetic lethal opportunities for the CDK cell cycle programs and the lead biologist for the cell panel screening program.